| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/02/2011 | CN101317996B Traditional Chinese medicine emplastrum for rheumatism of muscles and bones |
| 02/02/2011 | CN101259256B Chinese medicine for treating infantile enuresis |
| 02/02/2011 | CN101179953B Food composition for stimulating growth, comprising fraction isolated from mammalian colostrum or milk whey |
| 02/02/2011 | CN101156933B A medicine for treating cerebrovascular disease |
| 02/02/2011 | CN101015682B Medicine composition with compact bone substance density improving function, preparing process and quality controlling means thereof |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879605 Methods and compositions for tissue regeneration |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879363 Using live bacterial cultures to treat or reduce incidence of lactose intolerance in mammals |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879333 Methods for preparing and delivering adjuvant compositions |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2522246C Method of producing chondrocytes for transplantation |
| 02/01/2011 | CA2490896C Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/01/2011 | CA2483110C Use of a mare milk concentrate dried on a biologically inert, highly disperse matrix |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2445260C Buffer solution for electroporation and a method comprising the use of the same |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 02/01/2011 | CA2288943C Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/01/2011 | CA2282779C Formulation comprising an antigen, an adjuvant and an amino acid for use in immunization. |
| 02/01/2011 | CA2274902C Submucosa extracts |
| 01/27/2011 | WO2011011725A2 Use of toxoplasma and derived compositions to prevent or treat microbial infections |
| 01/27/2011 | WO2011011604A2 Composition and method to alleviate joint pain |
| 01/27/2011 | WO2011011388A2 Neuregulin induced regeneraton of heart muscle muscle |
| 01/27/2011 | WO2011011302A2 Differentiation of human embryonic stem cells |
| 01/27/2011 | WO2011011252A1 Methods of attenuating the loss of functional status |
| 01/27/2011 | WO2011010966A1 Pre-natal mesenchymal stem cells |
| 01/27/2011 | WO2010140162A3 A process for preparing stem cell based formulations |
| 01/27/2011 | WO2010133475A3 Infant feeding formulas comprising probiotic micro-organisms |
| 01/27/2011 | WO2010125565A3 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder |
| 01/27/2011 | US20110021970 Non-invasive energy upconversion methods and systems for in-situ photobiomodulation |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110020908 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020466 Fertilized egg isolate and use thereof |
| 01/27/2011 | US20110020465 Methods of treatment of gout using thymus-derived compositions |
| 01/27/2011 | US20110020464 Methods of treatment using thymus-derived compositions |
| 01/27/2011 | US20110020463 Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain caused by muscle spasm |
| 01/27/2011 | US20110020462 New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly |
| 01/27/2011 | US20110020461 Hyaluronate and colostrum compositions and methods of using the same |
| 01/27/2011 | US20110020460 Gpr 119 modulators |
| 01/27/2011 | US20110020459 Microfluidic method and system for isolating particles from biological fluid |
| 01/27/2011 | US20110020452 Progenitor cell replication and differentiation in 3d |
| 01/27/2011 | US20110020419 Osteoinductive calcium phosphates |
| 01/27/2011 | US20110020389 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020350 Contraceptives Based on SP22 and SP22 Antibodies |
| 01/27/2011 | US20110020316 Composition and method to alleviate joint pain |
| 01/27/2011 | US20110020314 Identifying haematopoietic stem cells based on cell surface markers |
| 01/27/2011 | US20110020310 Root canal filler and dental tissue regeneration method |
| 01/27/2011 | US20110020309 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergice disease |
| 01/27/2011 | US20110020308 Expression of transgenic t cell receptors in lak-t cells |
| 01/27/2011 | US20110020307 Compositions and methods for microbe storage and delivery |
| 01/27/2011 | US20110020306 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020305 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020304 Synbiotic mixture |
| 01/27/2011 | US20110020303 Novel use of probiotics |
| 01/27/2011 | US20110020302 Natural preservative blend |
| 01/27/2011 | US20110020301 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 01/27/2011 | US20110020300 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/27/2011 | US20110020299 Method and composition for the regeneration of tissue with the aid of stem cells or bone marrow cells |
| 01/27/2011 | US20110020298 Collagen-binding synthetic peptidoglycans, preparation, and methods of use |
| 01/27/2011 | US20110020297 Dner-mediated cell purification of pancreatic endocrine pre-progenitor cells and their progeny |
| 01/27/2011 | US20110020296 Methods for treating diseases and increasing longevity |
| 01/27/2011 | US20110020295 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 01/27/2011 | US20110020294 Inducement of organogenetic tolerance for pancreatic xenotransplant |
| 01/27/2011 | US20110020293 Use of Stem Cells to Reduce Leukocyte Extravasation |
| 01/27/2011 | US20110020292 Use of Stem Cells to Reduce Leukocyte Extravasation |
| 01/27/2011 | US20110020291 Use of stem cells for wound healing |
| 01/27/2011 | US20110020290 Bacteriophage-containing therapeutic agents |
| 01/27/2011 | US20110020288 Reoviruses Having Modified Sequences |
| 01/27/2011 | US20110020287 Parvovirus Cancer Therapy and Combination with Chemotherapy |
| 01/27/2011 | US20110020285 Composition Containing Cacao and Spirulina |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020283 Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans |
| 01/27/2011 | US20110020282 Recombinant newcastle disease virus |
| 01/27/2011 | US20110020274 Mobilization of hematopoietic stem cells |
| 01/27/2011 | US20110020271 Elastin for soft tissue augmentation |
| 01/27/2011 | US20110020220 Humanized antibodies against the beta-amyloid peptide |
| 01/27/2011 | US20110020216 Scaffolds for cell collection or elimination |
| 01/27/2011 | CA2768644A1 Differentiation of human embryonic stem cells |
| 01/27/2011 | CA2768576A1 Use of stem cells to reduce leukocyte extravasation |
| 01/27/2011 | CA2768471A1 Methods of attenuating the loss of functional status |
| 01/27/2011 | CA2767810A1 Methods for removal of microcystins and isolation of phycocyanin from cyanobacteria |
| 01/26/2011 | EP2277995A1 Method for preparation of platelet from ips cell |
| 01/26/2011 | EP2277992A2 Progenitor cells from Wharton's jelly of human umbilical cord |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277594A2 Lysis / resealing process and device for incorporating an active ingredient in erythrocytes |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277524A1 Treatment of IBD and IBS using both probiotec bacteria and fermented cereal as treatment effectors |
| 01/26/2011 | EP2276843A1 PROCESS FOR PRODUCING OILS COMPRISING PUFAS USING MICROORGANISMS OF THE LABYRINTHULOMYCOTA ORDER& xA; |
| 01/26/2011 | EP2276842A2 Method for obtaining oils by fermentation, containing polyunsaturated fatty acids (pufas) and having a modified fatty acid profile by using flocculants |
| 01/26/2011 | EP2276832A1 Plasmacytoid dendritic cell line used in active or adoptive cell therapy |
| 01/26/2011 | EP2276504A1 Vascular aging inhibitor and anti-aging formulation |
| 01/26/2011 | EP2276498A1 Use of probiotic bacteria for the treatment of hyperhomocysteinaemia |
| 01/26/2011 | EP2086556B1 Mixed cell populations for tissue repair and separation technique for cell processing |